Transgene Biotek Overview

  • Founded
  • 1991
Founded
  • Status
  • Public
  • Stock Symbol
  • 526139
Stock Symbol
  • Investments
  • 4
  • Share Price
  • $0.05
  • (As of Thursday Closing)

Transgene Biotek General Information

Description

Transgene Biotek Ltd is an India based research and development company. It is engaged in the research and development of molecules and technologies for the production of active pharmaceutical ingredients and different products. The group's product portfolio includes TrabiDHA, Tracolimus and Orlistat. It generates revenue from the provision of medical diagnostic services, research and development and sales of products.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Biotechnology
Other Industries
Drug Delivery
Drug Discovery
Stock Exchange
BOM
Primary Office
  • 69 & 70 IDA Bollaram
  • Sangareddy, Telangana 502325
  • India
+91 084582 00000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Transgene Biotek Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.05 $0.05 $0.04 - $0.08 $3.6M 75.8M 53.6K -$0.02

Transgene Biotek Financials Summary

In Thousands,
USD
TTM 30-Jun-2021 FY 2021 31-Mar-2021 FY 2020 31-Mar-2020 FY 2019 31-Mar-2019
EV 6,323 6,186 4,404 5,856
Revenue 23 23 1 10
EBITDA (34) (35) (96) 195
Net Income (1,410) (1,403) (1,543) (1,256)
Total Assets 6,398 22,110 25,421
Total Debt 0 1,543 1,369 1,315
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Transgene Biotek Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Transgene Biotek‘s full profile, request access.

Request a free trial

Transgene Biotek Executive Team (2)

Name Title Board Seat Contact Info
Prasad Chowdai Chief Financial Officer & Member of Risk Management Committee
Koteswara Rao Founder, Chairman of Risk Management Committee, Member of Audit Committee & Managing Director
To view Transgene Biotek’s complete executive team members history, request access »

Transgene Biotek Board Members (1)

Name Representing Role Since
000000 0000000 Transgene Biotek Chief Financial Officer & Member of Risk Management Committee 000 0000
To view Transgene Biotek’s complete board members history, request access »

Transgene Biotek Investments & Acquisitions (4)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 0000000000 31-Jul-2013 000000000000000000 Other Healthcare Services
00000000 000000000 23-May-2013 00000 00000 00 000.00 Drug Discovery
0000000 0000000 17-May-2013 00000 00000 00 00.000 Biotechnology
Marillion Pharmaceuticals 05-Aug-2010 Merger/Acquisition Drug Discovery
To view Transgene Biotek’s complete investments and acquisitions history, request access »

Transgene Biotek Subsidiaries (1)

Company Name Industry Location Founded
000000000 00000000 Drug Discovery Malvern, PA 0000
To view Transgene Biotek’s complete subsidiaries history, request access »

Transgene Biotek Exits (2)

Company Name Exit Date Exit Type Exit Size Status Buyers
00000000 000000000 23-May-2013 00000 00000 00 000.00 Completed
  • 000000000 000000
ElsaLys Biotech 17-May-2013 Early Stage VC 00.000 Completed
  • 2 buyers
To view Transgene Biotek’s complete exits history, request access »